Cargando…
Curcuma longa and Boswellia serrata Extracts Modulate Different and Complementary Pathways on Human Chondrocytes In Vitro: Deciphering of a Transcriptomic Study
Objectives: Curcuma longa (CL) and Boswellia serrata (BS) extracts are used to relieve osteoarthritis symptoms. The aim of this in vitro study was to investigate their mechanisms of action at therapeutic plasmatic concentrations on primary human osteoarthritic (OA) chondrocytes. Methods: BS (10–50 μ...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403192/ https://www.ncbi.nlm.nih.gov/pubmed/36034822 http://dx.doi.org/10.3389/fphar.2022.931914 |
_version_ | 1784773317687771136 |
---|---|
author | Sanchez, Christelle Zappia, Jérémie Lambert, Cécile Foguenne, Jacques Dierckxsens, Yvan Dubuc, Jean-Emile Delcour, Jean-Pierre Gothot, André Henrotin, Yves |
author_facet | Sanchez, Christelle Zappia, Jérémie Lambert, Cécile Foguenne, Jacques Dierckxsens, Yvan Dubuc, Jean-Emile Delcour, Jean-Pierre Gothot, André Henrotin, Yves |
author_sort | Sanchez, Christelle |
collection | PubMed |
description | Objectives: Curcuma longa (CL) and Boswellia serrata (BS) extracts are used to relieve osteoarthritis symptoms. The aim of this in vitro study was to investigate their mechanisms of action at therapeutic plasmatic concentrations on primary human osteoarthritic (OA) chondrocytes. Methods: BS (10–50 μg/ml) and CL (0.4–2 μg/ml corresponding to 1–5 µM of curcumin) were evaluated separately or in combination on primary chondrocytes isolated from 17 OA patients and cultured in alginate beads. Ten patients were used for RNA-sequencing analysis. Proteomic confirmation was performed either by immunoassays in the culture supernatant or by flow cytometry for cell surface markers after 72 h of treatment. Results: Significant gene expression modifications were already observed after 6 h of treatment at the highest dose of CL (2 μg/ml) while BS was significantly effective only after 24 h of treatment irrespective of the concentration tested. The most over-expressed genes by CL were anti-oxidative, detoxifying, and cytoprotective genes involved in the Nrf2 pathway. Down-regulated genes were principally pro-inflammatory cytokines and chemokines. Inversely, BS anti-oxidant/detoxifying activities were related to the activation of Nrf1 and PPARα pathways. BS anti-inflammatory effects were associated with the increase in GDF15, decrease in cholesterol cell intake and fatty acid metabolism-involved genes, and down-regulation of Toll-like receptors (TLRs) activation. Similar to CL, BS down-regulated ADAMTS1, 5, and MMP3, 13 genes expression. The combination of both CL and BS was significantly more effective than CL or BS alone on many genes such as IL-6, CCL2, ADAMTS1, and 5. Conclusion: BS and CL have anti-oxidative, anti-inflammatory, and anti-catabolic activities, suggesting a protective effect of these extracts on cartilage. Even if they share some mechanism of action, the two extracts act mainly on distinct pathways, and with different time courses, justifying their association to treat osteoarthritis. |
format | Online Article Text |
id | pubmed-9403192 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94031922022-08-26 Curcuma longa and Boswellia serrata Extracts Modulate Different and Complementary Pathways on Human Chondrocytes In Vitro: Deciphering of a Transcriptomic Study Sanchez, Christelle Zappia, Jérémie Lambert, Cécile Foguenne, Jacques Dierckxsens, Yvan Dubuc, Jean-Emile Delcour, Jean-Pierre Gothot, André Henrotin, Yves Front Pharmacol Pharmacology Objectives: Curcuma longa (CL) and Boswellia serrata (BS) extracts are used to relieve osteoarthritis symptoms. The aim of this in vitro study was to investigate their mechanisms of action at therapeutic plasmatic concentrations on primary human osteoarthritic (OA) chondrocytes. Methods: BS (10–50 μg/ml) and CL (0.4–2 μg/ml corresponding to 1–5 µM of curcumin) were evaluated separately or in combination on primary chondrocytes isolated from 17 OA patients and cultured in alginate beads. Ten patients were used for RNA-sequencing analysis. Proteomic confirmation was performed either by immunoassays in the culture supernatant or by flow cytometry for cell surface markers after 72 h of treatment. Results: Significant gene expression modifications were already observed after 6 h of treatment at the highest dose of CL (2 μg/ml) while BS was significantly effective only after 24 h of treatment irrespective of the concentration tested. The most over-expressed genes by CL were anti-oxidative, detoxifying, and cytoprotective genes involved in the Nrf2 pathway. Down-regulated genes were principally pro-inflammatory cytokines and chemokines. Inversely, BS anti-oxidant/detoxifying activities were related to the activation of Nrf1 and PPARα pathways. BS anti-inflammatory effects were associated with the increase in GDF15, decrease in cholesterol cell intake and fatty acid metabolism-involved genes, and down-regulation of Toll-like receptors (TLRs) activation. Similar to CL, BS down-regulated ADAMTS1, 5, and MMP3, 13 genes expression. The combination of both CL and BS was significantly more effective than CL or BS alone on many genes such as IL-6, CCL2, ADAMTS1, and 5. Conclusion: BS and CL have anti-oxidative, anti-inflammatory, and anti-catabolic activities, suggesting a protective effect of these extracts on cartilage. Even if they share some mechanism of action, the two extracts act mainly on distinct pathways, and with different time courses, justifying their association to treat osteoarthritis. Frontiers Media S.A. 2022-08-11 /pmc/articles/PMC9403192/ /pubmed/36034822 http://dx.doi.org/10.3389/fphar.2022.931914 Text en Copyright © 2022 Sanchez, Zappia, Lambert, Foguenne, Dierckxsens, Dubuc, Delcour, Gothot and Henrotin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Sanchez, Christelle Zappia, Jérémie Lambert, Cécile Foguenne, Jacques Dierckxsens, Yvan Dubuc, Jean-Emile Delcour, Jean-Pierre Gothot, André Henrotin, Yves Curcuma longa and Boswellia serrata Extracts Modulate Different and Complementary Pathways on Human Chondrocytes In Vitro: Deciphering of a Transcriptomic Study |
title |
Curcuma longa and Boswellia serrata Extracts Modulate Different and Complementary Pathways on Human Chondrocytes In Vitro: Deciphering of a Transcriptomic Study |
title_full |
Curcuma longa and Boswellia serrata Extracts Modulate Different and Complementary Pathways on Human Chondrocytes In Vitro: Deciphering of a Transcriptomic Study |
title_fullStr |
Curcuma longa and Boswellia serrata Extracts Modulate Different and Complementary Pathways on Human Chondrocytes In Vitro: Deciphering of a Transcriptomic Study |
title_full_unstemmed |
Curcuma longa and Boswellia serrata Extracts Modulate Different and Complementary Pathways on Human Chondrocytes In Vitro: Deciphering of a Transcriptomic Study |
title_short |
Curcuma longa and Boswellia serrata Extracts Modulate Different and Complementary Pathways on Human Chondrocytes In Vitro: Deciphering of a Transcriptomic Study |
title_sort | curcuma longa and boswellia serrata extracts modulate different and complementary pathways on human chondrocytes in vitro: deciphering of a transcriptomic study |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403192/ https://www.ncbi.nlm.nih.gov/pubmed/36034822 http://dx.doi.org/10.3389/fphar.2022.931914 |
work_keys_str_mv | AT sanchezchristelle curcumalongaandboswelliaserrataextractsmodulatedifferentandcomplementarypathwaysonhumanchondrocytesinvitrodecipheringofatranscriptomicstudy AT zappiajeremie curcumalongaandboswelliaserrataextractsmodulatedifferentandcomplementarypathwaysonhumanchondrocytesinvitrodecipheringofatranscriptomicstudy AT lambertcecile curcumalongaandboswelliaserrataextractsmodulatedifferentandcomplementarypathwaysonhumanchondrocytesinvitrodecipheringofatranscriptomicstudy AT foguennejacques curcumalongaandboswelliaserrataextractsmodulatedifferentandcomplementarypathwaysonhumanchondrocytesinvitrodecipheringofatranscriptomicstudy AT dierckxsensyvan curcumalongaandboswelliaserrataextractsmodulatedifferentandcomplementarypathwaysonhumanchondrocytesinvitrodecipheringofatranscriptomicstudy AT dubucjeanemile curcumalongaandboswelliaserrataextractsmodulatedifferentandcomplementarypathwaysonhumanchondrocytesinvitrodecipheringofatranscriptomicstudy AT delcourjeanpierre curcumalongaandboswelliaserrataextractsmodulatedifferentandcomplementarypathwaysonhumanchondrocytesinvitrodecipheringofatranscriptomicstudy AT gothotandre curcumalongaandboswelliaserrataextractsmodulatedifferentandcomplementarypathwaysonhumanchondrocytesinvitrodecipheringofatranscriptomicstudy AT henrotinyves curcumalongaandboswelliaserrataextractsmodulatedifferentandcomplementarypathwaysonhumanchondrocytesinvitrodecipheringofatranscriptomicstudy |